Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats

Pharmacological Research

Volumn 48, Issue 6, 2003, Pages 565-570

  Sathish, Venkatachalem ^a   Ebenezar, Kesavarao Kumar ^a   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Amlodipine; FFAs; Free fatty acids; Isoproterenol; Lipids; Mitochondrial respiration; Myocardial infarction; Nicorandil; Phospholipids; PL; RCR; Respiratory control ratio; TG; Triacylglycerol

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; ISOPRENALINE; LIPID; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; HEART INFARCTION; HEART PROTECTION; HISTOPATHOLOGY; LIPID COMPOSITION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMLODIPINE; ANIMALS; CARDIOVASCULAR AGENTS; DRUG SYNERGISM; ISOPROTERENOL; LIPID METABOLISM; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; NICORANDIL; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SUCCINIC ACID;

EID: 1542397850     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00223-8     Document Type: Article

References (34)

1. Purcell H., Fox K. Potassium channel openers in myocardial ischaemia-clinical experience with nicorandil. J. Clin. Basic Cardiol. 2:1999;12-14.
2. Markham A., Plosker G.L., Goa K.L. Nicorandil: an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs. 60:2000;955-974.
3. + channel openers? Trend Pharmacol. Sci. 20:1999;157-161.
4. ATP channel as a receptor for potassium channel openers. J. Biol. Chem. 271:1996;8796-8799.
5. Burges R.A., Dodd M.G. Amlodipine. Cardiovasc. Drug Rev. 8:1990;24-25.
6. Sandmann S., Class R., Cleutjens J.P., Daemen M.J., Unger T. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J. Cardiovasc. Pharmacol. 37:2001;64-67.
7. Janke J., Fleckenstein A., Doring H.J., Leder O. Key role of intracellular calcium overload in acute necrosis of the myocardium. Cardioprotection with verpamil. Minerva Med. 66:1975;1846-1858.
8. Burton K.P., McCord J.M., Ghai G. Myocardial alterations due to free radical generation. Am. J. Physiol. 246:1984;H776-H783.
9. Sathish V., Vimal V., Ebenezar K.K., Devaki T. Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol induced myocardial infarction in rats. J. Pharm. Pharmacol. 54:2002;133-137.
10. Sree Priya M., Saravanan N., Devaki T., Nayeem M. Protective effects of L-arginine on experimental myocardial injury induced by β-adrenergic stimulation in rats. J. Clin. Biochem. Nutr. 27:1999;19-26.
11. Sathish V., Vimal V., Ebenezar K.K., Devaki T. Synergistic effect of nicorandil and amlodipine on tissue defense system during experimental myocardial infarction in rats. Mol. Cell. Biochem. 243:2003;133-138.
12. Johnson D, Lardy H. Isolation of liver or kidney mitochondria. In: Estabrook RW, editor. Methods in enzymology. New York: Academic Press; 1967. p. 94-6.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin-phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Katyare S.S., Fatterpaker P., Sreenivasan A. Effect of 2,4-dinitrophenol (DNP) on oxidative phosphorylation in rat liver mitochondria. Arch. Biochem. Biophys. 144:1971;209-215.
15. Williamson JR, Corkey BE. Assays of intermediates of the citric acid cycle and related compounds by fluorimetric enzyme methods. In: Lowenstein JM, editor. Methods in enzymology. New York: Academic Press; 1969. p. 488-91.
16. Parekh A.C., Jung D.H. Cholesterol determination with ferric acetate-uranyl acetate and sulphuric acid-ferrous sulphate reagents. Anal. Chem. 42:1970;1423-1427.
17. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66:1925;375-400.
18. Foster L.B., Dunn R.T. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin. Chem. 19:1973;338-340.
19. Hron W.T., Menahan L.A. A sensitive method for the determination of free fatty acids in plasma. J. Lipid. Res. 122:1981;377-381.
20. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
21. Brown G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 284:1992;1-13.
22. Gottlieb R.A. Mitochondria and apoptosis. Biol. Signals Recept. 10:2001;147-161.
23. Ferrari R., Visioli O., Guarnieri C., Caldarera M. Vitamin E and the heart: possible role as antioxidant. Acta Vitaminol. Enzymol. 5:1983;11-22.
24. Saris N.E., Erikkson K.O. Mitochondrial dysfunction in ischaemia-reperfusion. Acta Anaesthesiol. Scand. Suppl. 107:1995;171-176.
25. Jarmakani J.M., Nagatomo T., Nakazawa M., Langer G.A. Effect of hypoxia on myocardial high-energy phosphates and in the neonatal mammalian heart. Am. J. Physiol. 235:1978;H475-H481.
26. Capozza G., Muolo L., Jirillo E., Guerrieri F. Isoproterenol causes changes in the mitochondrial energy metabolism in the rat heart. Cardiologia. 37:1992;663-665.
27. Singal P.K., Kapur N., Dhillon K.S., Beamish R.E., Dhalla N.S. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60:1982;1390-1397.
28. Santostasi G., Kutty R.K., Bartorelli A.L., Yasumoto T., Krishna G. Maitotoxin-induced myocardial cell injury: calcium accumulation followed by ATP depletion precedes cell death. Toxicol. Appl. Pharmacol. 102:1990;164-173.
29. Sakai K., Tsuchiya Y., Kitajima S., Hamada H. Myocardial distribution and biotransformation in vitro and in vivo of nicorandil in rats, with special reference to mitochondria. J. Cardiovasc. Pharmacol. 33:1999;163-168.
30. Venter H., Genade S., Mouton R., Huisamen B., Harper I.S., Lochner A. Myocardial membrane cholesterol: effects of ischaemia. J. Mol. Cell. Cardiol. 23:1991;1271-1286.
31. Rouslin W., MacGee J., Gupte S., Wesselman A., Epps D.E. Mitochondrial cholesterol content and membrane properties in porcine myocardial ischemia. Am. J. Physiol. 242:1982;H254-H259.
32. Laird D.M., Parce J.W., Montgomery R.I., Cunningham C.C. Effect of phospholipids on catalytic subunits of the mitochondiral F0. F1-ATPase. J. Biol. Chem. 261:1986;14851-14856.
33. Farber J.L., Young E.E. Accelerated phospholipid degradation in anoxic rat hepatocytes. Arch. Biochem. Biophys. 211:1981;312-320.
34. Bel'Chenko D.I., Sopka N.V., Kalinkin M.N., Khanina N.I.A., Chelnokov V.S. The metabolic changes in myocardial subcellular fractions in the pathogenesis of ischemic heart disease. Patol. Fiziol. Eksp. Ter. 2:1990;16-20.